AVACTA GROUP
Avacta Group plc is a provider of technologies, consumables and reagents for the life science markets, from drug discovery to diagnostics. It is engaged in the research, development, production and delivery of instrumentation and services for the biopharmaceutical drug development and clinical diagnostics markets using biophysical technology. The Company has two segments: Analytical and Animal Health. The Analytical segment provides tools and contract services for early stage protein characteris... ation and analysis for biopharmaceutical drug developers. The Animal Health provides tools and contract services to assist diagnosis of conditions in animals to enable faster treatment for veterinarians. The Company’s subsidiaries include Avacta Limited, Avacta Analytical Limited, Oriental Fine Foods Limited, Avacta Health Limited, TheraGenetics Limited and TheraGenetics Inc. ###Readybuy Plc acquires Avacta Ltd in a reverse merger and changed name to Avacta Group Plc in 2004. Readybuy was founded in 2003.###
AVACTA GROUP
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
2003-01-01
Address:
Wetherby, York, United Kingdom
Country:
United Kingdom
Website Url:
http://www.avacta.com
Total Employee:
51+
Status:
Active
Contact:
+08444140452
Email Addresses:
[email protected]
Total Funding:
34.2 M USD
Technology used in webpage:
Gravity Forms
Similar Organizations
Adamas Pharmaceuticals
Adamas Pharmaceuticals develops controlled release combination therapeutics for infectious diseases and central nervous system disorders.
Alkermes
Alkermes is a biotechnology company that develops, manufactures and commercializes medicines for the treatment of chronic diseases.
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Arrowhead Pharmaceuticals
Arrowhead Pharmaceuticals is a biotechnology company that focuses on the development of medicine to treat diseases with a genetic origin.
Aura Biosciences
Aura Biosciences is a biotechnology company that focuses on the development of drugs by using tumor targeted pseudovirions.
Emmaus Medical
Emmaus Medical is a pharmaceutical company developing new treatments for rare diseases and conditions.
PIQUR Therapeutics
PIQUR Therapeutics is a Swiss pharmaceutical company focusing on the discovery and development of anti-cancer drugs.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2023-06-01 | Coris BioConcept | Coris BioConcept acquired by Avacta Group | 7.4 M GBP |
| 2012-01-11 | Aptuscan | Aptuscan acquired by Avacta Group | N/A |
| 2010-01-01 | ReactivLab | ReactivLab acquired by Avacta Group | N/A |
| 2009-03-03 | Curidium Medica | Curidium Medica acquired by Avacta Group | 6.18 M GBP |
| 2009-02-09 | Avacta Animal Health | Avacta Animal Health acquired by Avacta Group | N/A |
| 2009-01-29 | TheraGenetics | TheraGenetics acquired by Avacta Group | 2 M GBP |
| 2007-11-14 | Oxford Medical Diagnostics | Oxford Medical Diagnostics acquired by Avacta Group | N/A |
Investors List
IP Group
IP Group investment in Post-IPO Equity - Avacta Group
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-04-13 | AffyXell Therapeutics | Avacta Group investment in Corporate Round - AffyXell Therapeutics | N/A |
Key Employee Changes
| Date | New article |
|---|---|
| 2024-05-01 | Avacta picks Christina Coughlin to replace long-serving CEO |
| 2023-03-28 | Avacta Appoints Karen Harrison as Chief Operating Officer for Therapeutics Division |
Official Site Inspections
http://www.avacta.com Semrush global rank: 1.47 M Semrush visits lastest month: 16.98 K
- Host name: 212-71-248-28.ip.linodeusercontent.com
- IP address: 212.71.248.28
- Location: London United Kingdom
- Latitude: 51.5164
- Longitude: -0.093
- Timezone: Europe/London
- Postal: EC2V
More informations about "Avacta Group"
Avacta Group - Crunchbase Company Profile & Funding
Avacta Group plc is a provider of technologies, consumables and reagents for the life science markets, from drug discovery to diagnostics. It is engaged in the …See details»
Avacta Group - Lab Manager
Apr 19, 2021 Organization profile for Avacta Group on Lab Manager. Avacta Group Avacta Group is focused on the development and commercialization of novel cancer therapies and …See details»
Avacta Therapeutics - LinkedIn
Avacta Therapeutics | 7,220 followers on LinkedIn. Expanding the reach of highly potent cancer therapies with the pre|CISION® platform. | Avacta is a clinical stage biotechnology company ...See details»
Avacta Group (AIM:AVCT) Company Profile & Description - Stock …
May 2, 2025 Avacta Group Plc develops cancer drugs and in vitro diagnostics in the United Kingdom, France, North America, South Korea, rest of Europe, and internationally. The …See details»
Avacta Group - Craft
Oct 29, 2024 Avacta Group plc is a provider of research reagents, consumables and equipment to the life sciences and animal care markets. The Company provides research, development, …See details»
AVACTA GROUP PLC - Investor Meet Company
Avacta Group Plc develops cancer therapies and diagnostics in the United Kingdom, France, North America, South Korea, and rest of Asia and Europe. The company operates through Diagnostics and Therapeutics segments. It …See details»
AVACTA GROUP PLC Company Profile - Dun & Bradstreet
Avacta works in the development, production, and sale of its in-house Affimer technology. Affimers are an engineered and highly-targeted alternative to antibodies that can tackle an …See details»
Avacta Group - Overview, News & Similar companies - ZoomInfo
Apr 30, 2024 Who is Avacta Group. Avacta is developing diagnostics and novel cancer immunotherapies based on its two proprietary platforms - Affimer® affinity reagents and …See details»
Corporate Governance | Avacta Therapeutics
Avacta’s Diagnostics Division completed the acquisition of Belgium-based Coris Bioconcept SRL, a developer and manufacturer of rapid tests focused on infectious diseases, on 1 June 2023 for an upfront consideration of £7.3 …See details»
Avacta Group Plc Company Profile - Overview - GlobalData
Avacta Group Plc (Avacta) is a clinical-stage biopharmaceutical company that focuses on developing innovative cancer therapeutics. The company's pipeline products include AVA6000 …See details»
Avacta - Trinity Delta
Mar 18, 2025 Avacta London, United Kingdom. Avacta is a UK-based clinical stage biotech focused on the novel pre|CISION platform to generate peptide-drug conjugates to target …See details»
Avacta Group (AVCTF) Company Profile & Description - Stock …
Feb 24, 2025 Avacta Group Plc develops cancer drugs and in vitro diagnostics in the United Kingdom, France, North America, South Korea, rest of Europe, and internationally. The …See details»
Avacta 2025 Company Profile: Stock Performance & Earnings
Avacta Group PLC is a United Kingdom-based biotechnology company. The company offers its products through three segments that are Diagnostics, Therapeutics, and Animal Health. The …See details»
Investor Resources | Avacta Therapeutics
Avacta Group plc. Scale Space, White City Imperial College Campus 58 Wood Lane London W12 7RZ +44 (0)20 3871 9700. Investor Enquiries . ICR Consilium 85 Gresham Street London …See details»
Avacta Group - Contacts, Employees, Board Members
Avacta Group plc is a provider of technologies, consumables and reagents for the life science markets, from drug discovery to diagnostics. ... Experience the new Crunchbase, powered by …See details»
Avacta Group Company Profile | Management and Employees List
Avacta is developing diagnostics and novel cancer immunotherapies based on its two proprietary platforms - Affimer® affinity reagents and pre|CISION™ tumour targeted chemotherapy. The …See details»
About | Avacta Therapeutics
Avacta Group plc. Scale Space, White City Imperial College Campus 58 Wood Lane London W12 7RZ +44 (0)20 3911 0353. Investor Enquiries . ICR Consilium 85 Gresham Street London …See details»
Investors | Avacta Therapeutics
Apr 28, 2025 Avacta Group plc. Scale Space, White City Imperial College Campus 58 Wood Lane London W12 7RZ +44 (0)20 3871 9700. Investor Enquiries . ICR Consilium 85 Gresham …See details»
Annual Reports | Avacta Therapeutics
Avacta Group plc. Scale Space, White City Imperial College Campus 58 Wood Lane London W12 7RZ +44 (0)20 3871 9700. Investor Enquiries . ICR Consilium 85 Gresham Street London …See details»
Board change | Avacta Therapeutics
Apr 29, 2025 LONDON and PHILADELPHIA – April 29, 2025 – Avacta Therapeutics (AIM: AVCT), a life sciences company developing innovative, targeted oncology drugs, today …See details»